| Literature DB >> 28469698 |
Chun-Yi Tsai1,2, Bo-Ru Lai1,2, Shang-Yu Wang2,3, Chien-Hung Liao2,3, Yu-Yin Liu1,2, Shih-Ching Kang2,3, Chun-Nan Yeh1,2, Yi-Yin Jan1,2, Ta-Sen Yeh1,2.
Abstract
BACKGROUND: Emergent pancreaticoduodenectomy is a life-saving procedure in certain clinical scenarios when all the conservative treatment fails. The indications can be limited into perforation and bleeding. To clarify the impact of etiology on surgical outcomes of emergent pancreaticoduodenectomy for non-trauma, we analyzed our patients and performed a literature review.Entities:
Keywords: Emergent pancreaticoduodenectomy; Gastrointestinal bleeding; Gastrointestinal perforation; Lethality; Pancreaticoduodenectomy; Surgical complication
Mesh:
Year: 2017 PMID: 28469698 PMCID: PMC5414322 DOI: 10.1186/s13017-017-0133-6
Source DB: PubMed Journal: World J Emerg Surg ISSN: 1749-7922 Impact factor: 5.469
Demographic data of patients who underwent emergent pancreaticoduodenectomy for non-traumatic etiologies in our series
| Sex/age/indication | Cancer | Procedure/blood loss (ml) | APACHE II score/BMI/Hb (g/dL)/albumin (g/dL) | Complication/grading | Death | Hospital stay (days) |
|---|---|---|---|---|---|---|
| M/70/internal bleeding after partial pancreatectomy | No | CW/1000 | 17/18.6/13.6/4.9 | Bile leakage/2 | No | 109 |
| M/49/bleeding duodenal lymphoma | Lymphoma | CW/20 | 16/20.1/11/2.2 | P-duct leakage with Peritonitis/3 | No | 54 |
| F/78/A-loop perforation after ERCP | GC | CW/400 | 12/21.3/9.4/3.3 | MOF/4 | Yesa | 16 |
| F/58/A-loop obstruction and perforation | No | CW/500 | 6/17.3/11.9/3.2 | Retro-peritoneal infection/3 | No | 17 |
| M/32/bowel ischemia | No | CW/2850 | 19/24.3/11.3/1.9 | Septic shock with liver and renal failure/5 | Yes | 11 |
| F/39/duodenal ulcer bleeding | No | CW/1000 | 17/19.5/4.5/2.2 | Wound infection/2 | No | 40 |
| 53.5 | 750 | 16.5/19.8/11.2/2.7 | 28.5 |
ERCP endoscopic retrograde cholangiopancreaticography, GC gastric cancer, CW classic Whipple’s operation, BMI body mass index, MOF multi-organ failure
aThe patient had been discharged and died of complications of MOF 8 months after initial EPD
Fig. 1The flow chart of patient selection. PD pancreaticoduodenectomy
Results of cases from literature review and our series
| Study year | Author | PD | EPD | EPD for non-trauma | Mortality rate | ||
|---|---|---|---|---|---|---|---|
| 2001 | Tuech | N/A | 1 | N/A | 0% | ||
| 2002 | Z’graggen | 417 | 4 | 1.0% | 4 | 1.0% | 25% |
| 2004 | Sakakima | N/A | 1 | N/A | 0% | ||
| 2006 | Maeda | N/A | 1 | N/A | 0% | ||
| 2007 | Stratigos | N/A | 1 | N/A | 0% | ||
| 2010 | Standop | 301 | 6 | 2.0% | 6 | 2.0% | 16.7% |
| 2010 | Hecker | N/A | 1 | N/A | 0% | ||
| 2010 | Michael | N/A | 1 | N/A | 0% | ||
| 2013 | Lupaşcu | N/A | 1 | N/A | 0% | ||
| 2014 | Gulla | 1166 | 10 | 0.9% | 3 | 0.3% | 0% |
| 2015 | Lissidini | 169 | 5 | 3.0% | 5 | 3.0% | 40% |
| Present study | 931 | 10 | 1.1% | 6 | 0.6% | 33.3% | |
| Overall | 2984 | 31 | 19.4% |
PD pancreaticoduodenectomy, EPD emergent pancreaticoduodenectomy
The 1:2 propensity score matching comparison (age and gender) between EPD and elective PD relating to surgical mortality
| EPD | Elective PD |
| |
|---|---|---|---|
| 31 | 62 | ||
| Gender | |||
| Male | 19 | 37 |
|
| Female | 12 | 25 | |
| Age | |||
| Mean (±S.D.) | 56.7 (14.5) | 57.2 (14.5) |
|
| Median | 58.0 | 58.0 | |
| Range | 32-85 | 29-86 | |
| Surgical mortality | |||
| Yes | 6 | 2 |
|
| No | 25 | 60 | |
| % | 19.4 | 3.2 | |
EPD emergent pancreatoduodenectomy, PD pancreatoduodenectomy
Univariate and multivariate logistic regression analysis of risk factors related to surgical mortality of the new cohort comprising 31 patients
| Variables | Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|---|
| OR | 95% CI |
| OR | 95% CI |
| ||
| Age | Year | 1.028 | 0.964–1.097 | 0.401 | 1.013 | 0.907–1.132 | 0.817 |
| Gender | Male vs. female | 3.929 | 0.399–38.704 | 0.241 | 19.174 | 0.468–785.328 | 0.119 |
| Etiology | Perforation vs. bleeding | 10.625 | 1.059–106.573 | 0.045 | 39.494 | 1.395–1117.856 | 0.031 |
| Cancer | Cancer vs. no cancer | 2.545 | 0.391–16.550 | 0.328 | 5.375 | 0.183–157.541 | 0.329 |
| Hospital stay | Day | 0.990 | 0.962–1.019 | 0.501 | 0.979 | 0.936–1.023 | 0.338 |